Researchers at Uppsala University and KTH Royal Institute of Technology have developed a new form of precision medicine, an antibody, with the potential to treat several types of cancer.
Tirzepatide Has Huge Impact on Weight, Even After Loss From Lifestyle Change
DALLAS — People who started taking a dual GLP-1/GIP receptor agonist after losing at least 5% of weight through intensive lifestyle intervention shed an additional